http://ift.tt/eA8V8J
Vertex Pharmaceuticals (VRTX) has had a great week. The drug maker released stellar late-stage clinical trial data late Tuesday for its new cystic fibrosis drug, and its share price has surged more than 20% in response. Is it too late to buy? Maxim Group analyst Jason McCarthy sees Vertex climbing another 34% in the next […]
March 31, 2017 at 06:52PM
http://ift.tt/2oGw0do
from Johanna Bennett
http://ift.tt/2oGw0do
Featured Post
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment